JP2020515286A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020515286A5 JP2020515286A5 JP2019567512A JP2019567512A JP2020515286A5 JP 2020515286 A5 JP2020515286 A5 JP 2020515286A5 JP 2019567512 A JP2019567512 A JP 2019567512A JP 2019567512 A JP2019567512 A JP 2019567512A JP 2020515286 A5 JP2020515286 A5 JP 2020515286A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- seq
- cancer
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762463868P | 2017-02-27 | 2017-02-27 | |
| US62/463,868 | 2017-02-27 | ||
| PCT/US2018/020050 WO2018157169A1 (en) | 2017-02-27 | 2018-02-27 | Antibody constructs and methods of treating cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020515286A JP2020515286A (ja) | 2020-05-28 |
| JP2020515286A5 true JP2020515286A5 (enExample) | 2022-01-04 |
| JP7325045B2 JP7325045B2 (ja) | 2023-08-14 |
Family
ID=63254387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019567512A Active JP7325045B2 (ja) | 2017-02-27 | 2018-02-27 | 癌を処置する抗体コンストラクトおよび方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11623953B2 (enExample) |
| EP (1) | EP3585819A4 (enExample) |
| JP (1) | JP7325045B2 (enExample) |
| CN (1) | CN111148760A (enExample) |
| CA (1) | CA3092434A1 (enExample) |
| WO (1) | WO2018157169A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118234748A (zh) * | 2021-05-19 | 2024-06-21 | 精密生物制品股份有限公司 | 用于治疗血液恶性肿瘤的方法和组合物 |
| WO2024091848A2 (en) * | 2022-10-25 | 2024-05-02 | The Trustees Of The University Of Pennsylvania | Anti-ceacam6 car-t cells for the treatment of ceacam6+ tumors |
| WO2025006562A1 (en) * | 2023-06-27 | 2025-01-02 | Bio4T2, Llc | Methods of car administration and treatment |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4737462A (en) | 1982-10-19 | 1988-04-12 | Cetus Corporation | Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β |
| US4518584A (en) | 1983-04-15 | 1985-05-21 | Cetus Corporation | Human recombinant interleukin-2 muteins |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| EP0940468A1 (en) | 1991-06-14 | 1999-09-08 | Genentech, Inc. | Humanized antibody variable domain |
| JP4287147B2 (ja) * | 2000-11-02 | 2009-07-01 | イミュノセルラー・セラピューティクス・リミテッド | 小細胞肺癌（ｓｃｌｃ）の検出および治療のためのモノクローナル抗体および細胞表面抗原 |
| EP3020413A1 (en) | 2002-01-30 | 2016-05-18 | The Brigham and Women's Hospital, Inc. | Compositions and methods related to TIM-3, a TH1-specific cell surface molecule |
| MXPA06003686A (es) | 2003-10-03 | 2007-03-01 | Brigham & Womens Hospital | Ligandos tim-3 y sus metodos. |
| JP2008537551A (ja) | 2005-03-31 | 2008-09-18 | カランド ファーマシューティカルズ， インコーポレイテッド | リボヌクレオチドレダクターゼサブユニット２の阻害剤およびその使用 |
| CN101607985B (zh) * | 2008-12-24 | 2013-03-27 | 中国科学院生物物理研究所 | 抗人cea的单克隆抗体，包含其的组合物，及其用途 |
| WO2012040824A1 (en) * | 2010-10-01 | 2012-04-05 | National Research Council Of Canada | Anti-ceacam6 antibodies and uses thereof |
| CN103421113B (zh) * | 2012-05-22 | 2018-01-19 | 武汉华鑫康源生物医药有限公司 | 抗BLyS抗体 |
| TWI742423B (zh) * | 2014-05-29 | 2021-10-11 | 美商宏觀基因股份有限公司 | 特異性結合多種癌症抗原的三特異性結合分子和其使用方法 |
| CA2980390A1 (en) * | 2015-03-23 | 2016-09-29 | Bayer Pharma Aktiengesellschaft | Anti-ceacam6 antibodies and uses thereof |
-
2018
- 2018-02-27 EP EP18758526.0A patent/EP3585819A4/en active Pending
- 2018-02-27 US US16/489,038 patent/US11623953B2/en active Active
- 2018-02-27 WO PCT/US2018/020050 patent/WO2018157169A1/en not_active Ceased
- 2018-02-27 JP JP2019567512A patent/JP7325045B2/ja active Active
- 2018-02-27 CN CN201880027595.6A patent/CN111148760A/zh active Pending
- 2018-02-27 CA CA3092434A patent/CA3092434A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112574307B (zh) | 抗人Claudin18.2抗体及其应用 | |
| JP7209464B2 (ja) | ヒトインターロイキン－２に対する免疫刺激性モノクローナル抗体 | |
| JP2020534830A5 (enExample) | ||
| JP6239503B2 (ja) | 新規な抗ｃｘｃｒ４抗体並びに癌の検出および診断のためのその使用 | |
| RU2018124602A (ru) | Новые анти-pd-l1 антитела | |
| JP2019527553A5 (enExample) | ||
| KR102661060B1 (ko) | 항인간 IgG4 모노클로날 항체, 및 그 항체를 이용한 인간 IgG4 측정 시약 | |
| JP2021500916A5 (enExample) | ||
| KR20130012132A (ko) | 암의 치료를 위한 인간화 항-cxcr4 항체들 | |
| JP2017538439A5 (enExample) | ||
| CN113227148B (zh) | 抗gpc3抗体、其抗原结合片段及其医药用途 | |
| CN112094348B (zh) | 抗人Tim3抗体或其功能性片段及其应用 | |
| JPWO2022256563A5 (enExample) | ||
| JP2020515286A5 (enExample) | ||
| JPWO2019217145A5 (enExample) | ||
| KR102350259B1 (ko) | Igf-1r 항체 및 암의 진단을 위한 그의 용도 | |
| CN105683755B (zh) | 陷阱分子和检测分子的用途及其相关试剂盒和组合物 | |
| CN116003615A (zh) | 一种抗卡利普多的单克隆抗体及其应用 | |
| WO2022074648A1 (en) | Marker for response to pd-1/pd-l1 immunotherapy | |
| CN116836291B (zh) | 抗cd47-cldn18.2双特异性抗体的抗独特型抗体及其制备方法和应用 | |
| TWI869740B (zh) | 一種體外檢測ｓＴＮＦＲ２蛋白濃度的方法及其檢測試劑和檢測試劑盒 | |
| US20190194319A1 (en) | Anti-ascl1 antibodies and methods of use | |
| WO2018213680A1 (en) | Diagnostic antibodies and methods of use | |
| JP6407990B2 (ja) | アウグリン免疫学的検定 | |
| TW201915016A (zh) | 單株抗體或其抗原結合片段及其用途 |